Ginkgo Bioworks (DNA) Misses Q4 EPS by 1c

Ginkgo Bioworks (NYSE: DNA) reported Q4 EPS of ($0.11), $0.01 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $34.76 million versus the consensus estimate of $42.5 million.

For earnings history and earnings-related data on Ginkgo Bioworks (DNA) click here.

You May Also Be Interested In

• MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
• KT&G approves KRW 360 billion share buyback and retirement plan
• CRH plc (CRH) PT Lowered to $135 at UBS, Buy Rating Maintained